No Data
No Data
Argenx Cut to Sell at Deutsche Bank on Valuation
FDA Approves Amgen Treatment For Pretreated Colorectal Cancer With Certain Mutation
Live Stock News: Market Climbs, TikTok Ban Confirmed, Intel for Sale, Week Ends with Positivity
'Ozempic Is In The Next Round Of Medicare Drug Price Negotiations. See The Full List Of 15 Medications' - CNBC
Sector Update: Health Care Stocks Rise Premarket Friday
Amgen Announced FDA Approval Of LUMAKRAS Combined With Vectibix For KRAS G12C-Mutated Metastatic Colorectal Cancer; Phase 3 CodeBreaK 300 Study Showed More Than Doubled Progression-Free Survival (5.6 Months) Compared To SOC (2 Months); Primary...
Living Stone : expenses and volume... good to know... thanks for sharing